Noninvasive evaluation of tumor immune microenvironment in patients with clear cell renal cell carcinoma using metabolic parameter from preoperative 2-[18F]FDG PET/CT.

Caixia WuYonggang CuiJumei LiuLinlin MaYan XiongYanqing GongYanyan ZhaoXi ZhangSilu ChenQun HeJianhua ZhangMeng LiuYan Fan

Published in: European journal of nuclear medicine and molecular imaging (2021)

Our findings demonstrated that 2-[18F]FDG PET/CT could provide metabolic information of TIME for ccRCC patients and develop image-guided therapeutic strategies accordingly. Patients with elevated preoperative SUVmax should be seriously considered, and perioperative immunotherapy might be beneficial for them.

Keyphrases

patients undergoing
end stage renal disease
ejection fraction
chronic kidney disease
stem cells
cardiac surgery
healthcare
acute kidney injury